Aurobindo Pharma (AUROPHARMA) Stock Overview

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

AUROPHARMA Stock Information

Symbol

AUROPHARMA

Address

Galaxy, Plot No. 1Hyderabad, 500032India

Founded

Trading hours

Website

https://www.aurobindo.com

Country

🇮🇳 India

Phone Number

91 40 6672 5000

Aurobindo Pharma (AUROPHARMA) Price Chart

Aurobindo Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$18.52	N/A
Market Cap	$10.85B	N/A
Shares Outstanding	585.94M	0.00%
Employees	23.45K	N/A
Shareholder Equity	268.52B	9.27%

Valuation	2023	Change
P/E Ratio	0.56	N/A
P/S Ratio	3.70	N/A
P/B Ratio	0.04	N/A

Growth	2023	Change
Return on Equity	0.0009	N/A

Earnings	2023	Change
Revenue	$2.93B	N/A
Earnings	$229.68M	N/A
EPS	32.90	N/A
Earnings Yield	1.78	N/A
Gross Margin	0.5166	N/A
Operating Margin	0.1031	N/A
Net income margin	0.0783	N/A

Financial Strength	2023	Change
Total Assets	$4.75B	N/A
Total Debt	$629.86M	N/A
Cash on Hand	$741.56M	N/A
Debt to Equity	0.0058	27.65%
Cash to Debt	$1.18	-15.30%
Current Ratio	$1.87	-15.64%